Chemokines in vasculitis

Frontiers in Bioscience - Elite

Volumn 1 E, Issue 1, 2009, Pages 26-35

  Eardley, Kevin Sean ^a   Smith, Stuart William ^b,c   Cockwell, Paul ^b,d  

^a ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ANCA; Chemokine receptors; Chemokines; Review; Systemic vasculitis

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR;

BLOOD; CLASSIFICATION; GLOMERULONEPHRITIS; HUMAN; IMMUNOLOGY; MONONUCLEAR CELL; NEUTROPHIL; PATHOLOGY; REVIEW; URINE; VASCULITIS;

CHEMOKINES, CXC; GLOMERULONEPHRITIS; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; RECEPTORS, CXCR; VASCULITIS;

EID: 84883287441     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. J. C. Jennette, R. J. Falk, K. Andrassy, P. A. Bacon, J. Churg, W. L. Gross, E. C. Hagen, G. S. Hoffman, G. G. Hunder, C. G. Kallenberg, R. T. McCluskey, R. A. Sinico, A. J. Rees, L. A. Van Es, R. Waldherr, A Wiik.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis & Rheumatism, 37(2), 187-92 (1994) (Pubitemid 24065492)
2. J. C. Jennette and R. J. Falk: Small-vessel vasculitis. N Engl J Med, 337(21), 1512-23 (1997) (Pubitemid 27495778)
3. L. Kamesh, L. Harper and C. O. Savage: ANCA-positive vasculitis. J Am Soc Nephrol, 13(7), 1953-60 (2002) (Pubitemid 34700622)
4. J. Savige, D. Davies, R. J. Falk, J. C. Jennette and A. Wiik: Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int, 57(3), 846-62 (2000) (Pubitemid 30434775)
5. C. O. Savage, L. Harper and M. Holland: New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis. Curr Opin Rheumatol, 14(1), 15-22 (2002) (Pubitemid 34059884)
6. J. C. Jennette, H. Xiao, R. J. Falk: Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. Journal of the American Society of Nephrology, 17(5), 1235-42 (2006) (Pubitemid 43673403)
7. H. Xiao, P. Heeringa, P. Hu, Z. Liu, M. Zhao, Y. Aratani, N. Maeda, R. J. Falk and J. C. Jennette: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.[see comment]. Journal of Clinical Investigation, 110(7), 955-63 (2002)
8. A. Howie: Handbook of Renal Biopsy Pathology. Kluwer Academic Publishers (2001)
9. P. Cockwell and C. O. Savage: Role of leukocytes in the immunopathogenesis of ANCA-associated glomerulonephritis. Nephron, 85(4), 287-306 (2000) (Pubitemid 30665857)
10. M. A. Little, C. D. Pusey and S. Nourshargh: Intravital microscopy in the study of ANCA-associated systemic vasculitis. Clin Nephrol, 64(6), 465-70 (2005) (Pubitemid 41819409)
11. P. Bindi, B. Mougenot, F. Mentre, L. H. Noel, M. N. Peraldi, P. Vanhille, P. Lesavre, F. Mignon and P. M. Ronco: Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med, 86(1), 55-68 (1993) (Pubitemid 23120804)
12. J. Markovic-Lipkovski, C. A. Muller, T. Risler, A. Bohle and G. A. Muller: Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis. Nephrol Dial Transplant, 5(1), 10-7 (1990) (Pubitemid 20105631)
13. E. Brouwer, M. G. Huitema, A. H. Mulder, P. Heeringa, H. van Goor, J. W. Tervaert, J. J. Weening and C. G. Kallenberg: Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int, 45(4), 1120-31 (1994) (Pubitemid 24234730)
14. P. Cockwell, C. J. Brooks, D. Adu, C. O. Savage: Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.[see comment]. Kidney International, 55(3), 852-63 (1999) (Pubitemid 29100697)
15. S. P. Berger, M. A. Seelen, P. S. Hiemstra, J. S. Gerritsma, E. Heemskerk, F. J. van der Woude, M. R. Daha: Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. Journal of the American Society of Nephrology, 7(5), 694-701 (1996) (Pubitemid 27466002)
16. S. Ohlsson, J. Wieslander, M. Segelmark, S. Ohlsson: Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome? Mediators of Inflammation, 13(4), 275-83 (2004) (Pubitemid 39573536)
17. W. Y. Tse, G. B. Nash, P. Hewins, C. O. Savage, D. Adu: ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation. Kidney International, 67(1), 130-9 (2005) (Pubitemid 40019234)
18. H. Haller, J. Eichhorn, K. Pieper, U. Gobel and F. C. Luft: Circulating leukocyte integrin expression in Wegener's granulomatosis. J Am Soc Nephrol, 7(1), 40-8 (1996) (Pubitemid 26067090)
19. D. R. Ralston, C. B. Marsh, M. P. Lowe, M. D. Wewers: Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. Journal of Clinical Investigation, 100(6), 1416-24 (1997) (Pubitemid 27425766)
20. S. Segerer, A. Henger, H. Schmid, M. Kretzler, D. Draganovici, U. Brandt, E. Noessner, P. J. Nelson, D. Kerjaschki, D. Schlondorff and H. Regele: Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney International, 69(10), 1765-73 (2006) (Pubitemid 43739203)
21. J. W. Calderwood, J. M. Williams, M. D. Morgan, G. B. Nash and C. O. S. Savage: ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium. Journal of Leukocyte Biology, 77(1), 33-43 (2005) (Pubitemid 40310690)
22. D. J. Radford, N. T. Luu, P. Hewins, G. B. Nash and C. O. Savage: Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis & Rheumatism, 44(12), 2851-61 (2001) (Pubitemid 34016205)
23. M. A. Little, C. L. Smyth, R. Yadav, L. Ambrose, H. T. Cook, S. Nourshargh and C. D. Pusey: Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood, 106(6), 2050-8 (2005) (Pubitemid 41291719)
24. F. Ferrario and M. P. Rastaldi: Histopathological atlas of renal diseases: ANCA-associated vasculitis (Second part). J Nephrol, 18(3), 217-20 (2005) (Pubitemid 41078938)
25. B. H. Rovin, M. Rumancik, L. Tan and J. Dickerson: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest, 71(4), 536-42 (1994) (Pubitemid 24338161)
26. W. Prodjosudjadi, J. S. Gerritsma, L. A. van Es, M. R. Daha and J. A. Bruijn: Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol, 44(3), 148-55 (1995)
27. P. Cockwell, A. J. Howie, D. Adu and C. O. Savage: In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney International, 54(3), 827-36 (1998) (Pubitemid 28397400)
28. T. Wada, K. Furuichi, C. Segawa-Takaeda, M. Shimizu, N. Sakai, S. I. Takeda, K. Takasawa, H. Kida, K. I. Kobayashi, N. Mukaida, Y. Ohmoto, K. Matsushima and H. Yokoyama: MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney International, 56(3), 995-1003 (1999) (Pubitemid 29411726)
29. S. Segerer, Y. Cui, K. L. Hudkins, T. Goodpaster, F. Eitner, M. Mack, D. Schlondorff and C. E. Alpers: Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. Journal of the American Society of Nephrology, 11(12), 2231-42 (2000)
30. H. Hasegawa, M. Kohno, M. Sasaki, A. Inoue, M. R. Ito, M. Terada, K. Hieshima, H. Maruyama, J. Miyazaki, O. Yoshie, M. Nose and S. Fujita: Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum, 48(9), 2555-66 (2003) (Pubitemid 37129432)
31. L. Gesualdo, G. Grandaliano, E. Ranieri, R. Monno, V. Montinaro, C. Manno and F. P. Schena: Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. Kidney Int, 51(1), 155-63 (1997) (Pubitemid 27064533)
32. Y. Zhou, D. Huang, C. Farver and G. S. Hoffman: Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. J Rheumatol, 30(7), 1541-7 (2003) (Pubitemid 36835453)
33. T. Imai, K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall and O. Yoshie: Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell, 91(4), 521-30 (1997) (Pubitemid 27508241)
34. A. M. Fong, L. A. Robinson, D. A. Steeber, T. F. Tedder, O. Yoshie, T. Imai and D. D. Patel: Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. Journal of Experimental Medicine, 188(8), 1413-9 (1998) (Pubitemid 28489578)
35. V. Bjerkeli, J. K. Damas, B. Fevang, J. C. Holter, P. Aukrust and S. S. Froland: Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis-possible role in vascular inflammation. Rheumatology (Oxford), 46(9), 1422-7 (2007) (Pubitemid 47317087)
36. P. Cockwell, S. J. Chakravorty, J. Girdlestone and C. O. Savage: Fractalkine expression in human renal inflammation. Journal of Pathology, 196(1), 85-90 (2002)
37. K. Furuichi, T. Wada, Y. Iwata, N. Sakai, K. Yoshimoto, M. Shimizu, K. Kobayashi, K. Takasawa, H. Kida and S. Takeda: Upregulation of fractalkine in human crescentic glomerulonephritis. Nephron, 87(4), 314-20 (2001) (Pubitemid 32260831)
38. S. Chen, K. B. Bacon, L. Li, G. E. Garcia, Y. Xia, D. Lo, D. A. Thompson, M. A. Siani, T. Yamamoto, J. K. Harrison and L. Feng: In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. Journal of Experimental Medicine, 188(1), 193-8 (1998) (Pubitemid 28328617)
39. A. Inoue, H. Hasegawa, M. Kohno, M. R. Ito, M. Terada, T. Imai, O. Yoshie, M. Nose and S. Fujita: Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum, 52(5), 1522-33 (2005) (Pubitemid 40663944)
40. S. Segerer, E. Hughes, K. L. Hudkins, M. Mack, T. Goodpaster and C. E. Alpers: Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney International, 62(2), 488-95 (2002) (Pubitemid 34779759)
41. S. Qin, J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser and C. R. Mackay: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest, 101(4), 746-54 (1998) (Pubitemid 28096070)
42. P. Romagnani, C. Beltrame, F. Annunziato, L. Lasagni, M. Luconi, G. Galli, L. Cosmi, E. Maggi, M. Salvadori, C. Pupilli and M. Serio: Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. Journal of the American Society of Nephrology, 10(12), 2518-26 (1999)
43. S. Segerer, B. Banas, M. Wornle, H. Schmid, C. D. Cohen, M. Kretzler, M. Mack, E. Kiss, P. J. Nelson, D. Schlondorff and H. J. Grone: CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol, 164(2), 635-49 (2004) (Pubitemid 38364678)
44. P. Romagnani, E. Lazzeri, L. Lasagni, C. Mavilia, C. Beltrame, M. Francalanci, M. Rotondi, F. Annunziato, L. Maurenzig, L. Cosmi, G. Galli, M. Salvadori, E. Maggi and M. Serio: IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. Journal of the American Society of Nephrology, 13(1), 53-64 (2002) (Pubitemid 34042011)
45. U. Panzer, O. M. Steinmetz, R. R. Reinking, T. N. Meyer, S. Fehr, A. Schneider, G. Zahner, G. Wolf, U. Helmchen, P. Schaerli, R. A. Stahl and F. Thaiss: Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol, 17(2), 454-64 (2006)
46. U. Panzer, O. M. Steinmetz, H. J. Paust, C. Meyer-Schwesinger, A. Peters, J. E. Turner, G. Zahner, F. Heymann, C. Kurts, H. Hopfer, U. Helmchen, F. Haag, A. Schneider and R. A. Stahl: Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol, 18(7), 2071-84 (2007) (Pubitemid 47041073)
47. S. Segerer, H. Regele, M. MacK, R. Kain, J. P. Cartron, Y. Colin, D. Kerjaschki and D. Schlondorff: The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis.[see comment]. Kidney International, 58(4), 1546-56 (2000)
48. E. A. Torheim, A. Yndestad, V. Bjerkeli, B. Halvorsen, P. Aukrust, S. S. Froland: Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro. Clinical & Experimental Immunology, 140(2), 376-83 (2005) (Pubitemid 40559167)
49. C. Holmen, E. Elsheikh, P. Stenvinkel, A. R. Qureshi, E. Pettersson, S. Jalkanen, S. Sumitran-Holgersson: Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. Journal of the American Society of Nephrology, 16(10), 3110-20 (2005) (Pubitemid 44743509)
50. V. Tesar, Z. Masek, I. Rychlik, M. Merta, J. Bartunkova, A. Stejskalova, J. Zabka, I. Janatkova, T. Fucikova, C. Dostal and R. Becvar: Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant, 13(7), 1662-7 (1998) (Pubitemid 28306791)
51. L. Freire Ade, M. B. Bertolo, A. J. de Pinho, Jr., A. M. Samara and S. R. Fernandes: Increased serum levels of interleukin-8 in polyarteritis nodosa and Behcet's disease. Clinical Rheumatology, 23(3), 203-5 (2004) (Pubitemid 38812196)
52. N. K. Tripathy, N. Sinha and S. Nityanand: Interleukin-8 in Takayasu's arteritis: plasma levels and relationship with disease activity. Clinical & Experimental Rheumatology, 22(6 Suppl 36), S27-30 (2004)
53. M. Matsunawa, T. Isozaki, T. Odai, N. Yajima, H. T. Takeuchi, M. Negishi, H. Ide, M. Adachi and T. Kasama: Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. Arthritis & Rheumatism, 54(11), 3408-16 (2006) (Pubitemid 44737151)
54. V. Dhawan, N. Mahajan and S. Jain: Role of C-C chemokines in Takayasu's arteritis disease. Int J Cardiol, 112(1), 105-11 (2006) (Pubitemid 44247192)
55. F. W. Tam, J. S. Sanders, A. George, T. Hammad, C. Miller, T. Dougan, H. T. Cook, C. G. Kallenberg, G. Gaskin, J. B. Levy and C. D. Pusey: Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrology Dialysis Transplantation, 19(11), 2761-8 (2004) (Pubitemid 39480970)
56. T. Ellingsen, P. Elling, A. Olson, H. Elling, U. Baandrup, K. Matsushima, B. Deleuran, K. Stengaard-Pedersen: Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica. Annals of the Rheumatic Diseases, 59(10), 775-80 (2000)
57. M. C. Cid, M. P. Hoffman, J. Hernandez-Rodriguez, M. Segarra, M. Elkin, M. Sanchez, C. Vilardell, A. Garcia-Martinez, M. Pla-Campo, J. M. Grau, H. K. Kleinman: Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis. Rheumatology, 45(11), 1356-63 (2006) (Pubitemid 44605469)
58. M. M. Amoli, F. Salway, E. Zeggini, W. E. Ollier, M. A. Gonzalez-Gay: MCP-1 gene haplotype association in biopsy proven giant cell arteritis. Journal of Rheumatology, 32(3), 507-10 (2005) (Pubitemid 40381423)
59. W. M. Krupa, M. Dewan, M. S. Jeon, P. J. Kurtin, B. R. Younge, J. J. Goronzy and C. M. Weyand: Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. American Journal of Pathology, 161(5), 1815-23 (2002) (Pubitemid 35265539)
60. W. Ma-Krupa, M. S. Jeon, S. Spoerl, T. F. Tedder, J. J. Goronzy, C. M. Weyand, W: Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. Journal of Experimental Medicine, 199(2), 173-83 (2004) (Pubitemid 38129698)
61. W. B. Breunis, M. H. Biezeveld, J. Geissler, I. M. Kuipers, J. Lam, J. Ottenkamp, A. Hutchinson, R. Welch, S. J. Chanock and T. W. Kuijpers: Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol, 150(1), 83-90 (2007) (Pubitemid 47383291)
62. I. Neumann, R. Birck, M. Newman, P. Schnulle, W. Kriz, K. Nemoto, B. Yard, R. Waldherr and F. J. Van der Woude: SCG/Kinjoh mice: a model of ANCA-associated crescentic glomerulonephritis with immune deposits. Kidney Int, 64(1), 140-8 (2003) (Pubitemid 36714166)
63. M. Samson, F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart and M. Parmentier: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382(6593), 722-5 (1996)
64. M. M. Amoli, W. Thomson, A. H. Hajeer, M. C. Calvino, C. Garcia-Porrua, W. E. Ollier, M. A. Gonzalez-Gay: Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. Journal of Rheumatology, 29(11), 2367-70 (2002) (Pubitemid 35266027)
65. K. Furuichi, T. Wada, N. Sakai, Y. Iwata, K. Yoshimoto, M. Shimizu, K. Kobayashi, K. Takasawa, H. Kida, S. I. Takeda, N. Mukaida, K. Matsushima and H. Yokoyama: Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. American Journal of Nephrology, 20(4), 291-9 (2000)
66. S. J. Chakravorty, A. J. Howie, J. Girdlestone, D. Gentle and C. O. Savage: Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation. Journal of Pathology, 194(2), 239-46 (2001)
67. S. Segerer, K. M. Mac, H. Regele, D. Kerjaschki and D. Schlondorff: Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney International, 56(1), 52-64 (1999) (Pubitemid 29300521)